Targeting the mycobacterial envelope for tuberculosis drug development.
about
Synthesis of α-Glucan in Mycobacteria Involves a Hetero-octameric Complex of Trehalose Synthase TreS and Maltokinase Pep2Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric InhibitorsComparative genomics for mycobacterial peptidoglycan remodelling enzymes reveals extensive genetic multiplicityEvolution of Mycolic Acid Biosynthesis Genes and Their Regulation during Starvation in Mycobacterium tuberculosis.Targeting the trehalose utilization pathways of Mycobacterium tuberculosisRifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis.Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.Depleting Mycobacterium tuberculosis of the transcription termination factor Rho causes pervasive transcription and rapid deathMmpL3 a potential new target for development of novel anti-tuberculosis drugs.Cell division in CorynebacterineaeCounterattacking drug-resistant tuberculosis: molecular strategies and future directions.A rapid screening assay for identifying mycobacteria targeted nanoparticle antibiotics.Systematic Identification of Mycobacterium tuberculosis Effectors Reveals that BfrB Suppresses Innate Immunity.Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis.Biochemical and functional characterizations of tyrosine phosphatases from pathogenic and nonpathogenic mycobacteria: indication of phenyl cyclopropyl methyl-/phenyl butenyl azoles as tyrosine phosphatase inhibitors.An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis.α-pyrones and their hydroxylated analogs as promising scaffolds against Mycobacterium tuberculosis.Cyclipostins and Cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo.Chemistry of Peptidoglycan in Mycobacterium tuberculosis Life Cycle: An off-the-wall Balance of Synthesis and Degradation.Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII8-12.Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
P2860
Q27679300-3CB32282-E87A-4705-AAFF-67771B2AE9A1Q27684704-13EA2B54-EF82-49AB-B64F-B9B7E795204DQ35128909-ACB80428-7DB1-4422-8652-34987B5639FEQ36297481-64DF2719-A5DE-4F1A-94AB-302128F6F1D9Q36629840-F320893F-CADA-4403-9CF3-BABC0E2B2588Q37065759-7A165B57-2AB4-4FB1-83C2-3AD0354DDA82Q37403156-228442C9-509A-450B-B6EF-D1A4043CAA02Q37736367-73FA9492-622F-4F7B-B750-CD09E23ED8D3Q38170188-D0D9A4C2-3AA3-411B-9A77-5A8526FE7509Q38208303-D6DDF2CD-3581-4FEF-A84E-57B9147E686DQ38547598-74C3797D-C422-432C-AB66-1C17CD68911CQ40262337-4BD9A4F5-CE61-4B19-B794-82FC76959193Q41919760-2B096B1C-1874-4167-965C-0A4B705A8397Q42673180-1A219EBD-B396-4A91-B04A-4B14B5C603C4Q46762736-02A63AD2-FC84-4C1C-A453-97724468DDA6Q47606759-8FF7DB58-0F2B-486A-BBCD-4EAB8235C2ABQ47873412-20C1805E-F708-4530-9113-30C5809B9845Q48550005-4C4F5516-701B-42A2-9A5A-CDD73ADE47CEQ50025811-8E5BD9D7-8C48-43AA-9655-8512DC9E971AQ50087921-92F26E00-9B27-4CEE-8207-A60C89E45EBDQ57656314-2EE44785-152A-4D1F-A51A-AE8DD9BB4C5E
P2860
Targeting the mycobacterial envelope for tuberculosis drug development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting the mycobacterial envelope for tuberculosis drug development.
@en
type
label
Targeting the mycobacterial envelope for tuberculosis drug development.
@en
prefLabel
Targeting the mycobacterial envelope for tuberculosis drug development.
@en
P2860
P356
P1476
Targeting the mycobacterial envelope for tuberculosis drug development.
@en
P2093
Lorenza Favrot
P2860
P304
P356
10.1586/ERI.12.91
P577
2012-09-01T00:00:00Z